Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemia inhibitory factor: a novel bone-active cytokine.

L R Reid1, C Lowe, J Cornish

  • 1Department of Medicine, University of Auckland, New Zealand.

Endocrinology
|March 1, 1990
PubMed
Summary

Leukemia inhibitory factor (LIF) stimulates bone resorption via prostaglandin production. LIF also promotes DNA and protein synthesis through separate mechanisms, representing a novel factor in bone cell regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Twelve-Month Observation Analysis of Real-Time Contact Pressure-Controlled Powered Tooth Brushing as a Subgroup Analysis of a 36-Month RCT.

International journal of dental hygiene·2026
Same author

Superradiant emission in a high-mobility two-dimensional electron gas.

Journal of physics. Condensed matter : an Institute of Physics journal·2023
Same author

Model validation for a knowledge and practices survey towards prevention of soil-transmitted helminth infections in rural villages in Indonesia.

Scientific reports·2023
Same author

In vivo clonal tracking reveals evidence of haemangioblast and haematomesoblast contribution to yolk sac haematopoiesis.

Nature communications·2023
Same author

Using adsorption kinetics to assemble vertically aligned nanorods at liquid interfaces for metamaterial applications.

Physical chemistry chemical physics : PCCP·2022
Same author

Unemployed individuals contact GPs more frequently but report lower satisfaction: results of the population-based DEGS1 and the GPCare-1 patient survey.

Scientific reports·2022

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Cytokines regulate bone resorption, with some sharing properties of osteoclast-activating factor.
  • Differentiation-inducing factor (DIF) shares properties with leukemia inhibitory factor (LIF).

Purpose of the Study:

  • To assess the effects of recombinant LIF on bone resorption and other parameters in neonatal mouse calvaria.
  • To investigate the mechanisms underlying LIF's effects on bone cell function.

Main Methods:

  • Administered recombinant murine and human LIF to neonatal mouse calvaria.
  • Measured 45Ca release to assess bone resorption.
  • Quantified osteoclast numbers.
  • Assessed [3H] thymidine and [3H] phenylalanine incorporation for DNA and protein synthesis.

Related Experiment Videos

  • Utilized indomethacin to block prostaglandin production.

    • Main Results:

    • Both murine and human LIF dose-dependently stimulated 45Ca release, indicating increased bone resorption.
    • LIF increased osteoclast numbers per bone area.
    • The osteolytic effect of human LIF was blocked by indomethacin, suggesting prostaglandin involvement.
    • LIF stimulated [3H] thymidine and [3H] phenylalanine incorporation via distinct, non-prostaglandin-mediated pathways.

    Conclusions:

    • LIF stimulates bone resorption through a prostaglandin-dependent mechanism.
    • LIF stimulates DNA and protein synthesis via separate mechanisms.
    • LIF represents a novel cytokine involved in bone cell regulation, distinct from other known bone-active cytokines.